These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11963437)

  • 1. Improved accuracy from point-of-care heparin tests.
    Healthc Benchmarks; 2002 Apr; 9(4):43-5. PubMed ID: 11963437
    [No Abstract]   [Full Text] [Related]  

  • 2. [Difference in examination of coagulation function in heparin anticoagulant therapy between point of care tests and automatic coagulation analyzer].
    Li J; Cong YL; Tu GH; Yang L; Zhu BB; Jin L
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1269-71. PubMed ID: 17686264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assessment in point-of-care coagulation testing.
    Kitchen DP; Kitchen S; Jennings I; Woods T; Walker I
    Semin Thromb Hemost; 2008 Oct; 34(7):647-53. PubMed ID: 19085765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices.
    Ganter MT; Hofer CK
    Anesth Analg; 2008 May; 106(5):1366-75. PubMed ID: 18420846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bedside activated partial thromboplastin time monitoring: just a matter of time?
    Patel VB; Moliterno DJ
    Am Heart J; 1999 Jan; 137(1):8-11. PubMed ID: 9878931
    [No Abstract]   [Full Text] [Related]  

  • 6. Coagulation assays.
    Bates SM; Weitz JI
    Circulation; 2005 Jul; 112(4):e53-60. PubMed ID: 16043649
    [No Abstract]   [Full Text] [Related]  

  • 7. Heparin therapy and monitoring: a role for the chromogenic antifactor Xa assay.
    Rosén S; Casoni MC
    Am Clin Lab; 2001 Aug; 20(7):35-8. PubMed ID: 11570272
    [No Abstract]   [Full Text] [Related]  

  • 8. Point of care testing for INR monitoring: where are we now?
    Murray ET; Fitzmaurice DA; McCahon D
    Br J Haematol; 2004 Nov; 127(4):373-8. PubMed ID: 15521913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the CoaguChek XS Plus system in a Swiss community setting.
    Deom A; Reber G; Tsakiris DA; Hannes FM; Plesch W
    Thromb Haemost; 2009 May; 101(5):988-90. PubMed ID: 19404558
    [No Abstract]   [Full Text] [Related]  

  • 10. Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin.
    Bauman ME; Black KL; Massicotte MP; Bauman ML; Kuhle S; Howlett-Clyne S; Cembrowski GS; Bajzar L
    Thromb Haemost; 2008 Jun; 99(6):1097-103. PubMed ID: 18521514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Point-of-care testing of hemostatic alterations in anaesthesia and intensive care].
    Calatzis A; Heesen M; Spannagl M
    Anaesthesist; 2003 Mar; 52(3):229-37. PubMed ID: 12666005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines on the use and monitoring of heparin.
    Baglin T; Barrowcliffe TW; Cohen A; Greaves M;
    Br J Haematol; 2006 Apr; 133(1):19-34. PubMed ID: 16512825
    [No Abstract]   [Full Text] [Related]  

  • 13. Implementing a standardized POCT coagulation system.
    West M; Ebey B; Wobb D; Woods M; Holtwick JJ; Meyer LS; Clark KS
    MLO Med Lab Obs; 2001 Jun; 33(6):28-30, 32, 37. PubMed ID: 11424286
    [No Abstract]   [Full Text] [Related]  

  • 14. Accuracy of capillary whole blood international normalized ratio on the CoaguChek S, CoaguChek XS, and i-STAT 1 point-of-care analyzers.
    Karon BS; McBane RD; Chaudhry R; Beyer LK; Santrach PJ
    Am J Clin Pathol; 2008 Jul; 130(1):88-92. PubMed ID: 18550476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity and specificity of a quantitative point of care D-dimer assay using heparinized whole blood, in patients with clinically suspected deep vein thrombosis.
    Dempfle CE; Korte W; Schwab M; Zerback R; Huisman MV;
    Thromb Haemost; 2006 Jul; 96(1):79-83. PubMed ID: 16807655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative coagulation management and blood conservation in cardiac surgery: a Canadian Survey.
    Taneja R; Fernandes P; Marwaha G; Cheng D; Bainbridge D
    J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):662-9. PubMed ID: 18922420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A little coagulation knowledge can be dangerous!
    Spiess BD
    Can J Anaesth; 2009 Jul; 56(7):478-82. PubMed ID: 19440809
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin concentrations in neonates during cardiopulmonary bypass: a rebuttal.
    Ignjatovic V; Newall F; Monagle P
    J Thromb Haemost; 2012 Sep; 10(9):1972. PubMed ID: 22642367
    [No Abstract]   [Full Text] [Related]  

  • 20. [Measurement of K(+) Na(+) Cl(-) concentrations in blood samples with heparin anticoagulation in emergency].
    Yang HW; Wang LX
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Mar; 15(3):179. PubMed ID: 12831626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.